Cargando…

Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A Review

Inflammatory bowel diseases (IBD) are a group of chronic inflammatory gastrointestinal (GI) disorders, mainly represented by Crohn's disease and ulcerative colitis. Although the etiology of IBD is not fully understood, there is substantial evidence that immunologic, genetic, and environmental f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sałaga, Maciej, Zatorski, Hubert, Sobczak, Marta, Chen, Chunqiu, Fichna, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Lower Gastrointestinal Cancers (AB Benson, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147240/ https://www.ncbi.nlm.nih.gov/pubmed/24792017 http://dx.doi.org/10.1007/s11864-014-0288-2

Ejemplares similares

Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer
por: Szczepaniak, Adrian, et al.
Publicado: (2020)

Optimal Strategies for Colorectal Cancer Screening
por: Jain, Shailavi, et al.
Publicado: (2022)

Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic
por: Mukherji, Reetu, et al.
Publicado: (2021)

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021)

Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?
por: Mjahed, Ribal Bou, et al.
Publicado: (2022)

Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management
por: Balyasnikova, Svetlana, et al.
Publicado: (2016)

Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities
por: Liu, Ge, et al.
Publicado: (2022)

Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light
por: Zhang, Jie, et al.
Publicado: (2022)

Experimental colitis in mice is attenuated by topical administration of chlorogenic acid
por: Zatorski, Hubert, et al.
Publicado: (2015)

Imaging Advances in Colorectal Cancer
por: Balyasnikova, Svetlana, et al.
Publicado: (2016)

What is the Future of the Gut Microbiota-Related Treatment? Toward Modulation of Microbiota in Preventive and Therapeutic Medicine
por: Zatorski, Hubert, et al.
Publicado: (2014)

AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice
por: Zatorski, Hubert, et al.
Publicado: (2021)

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
por: Sobczak, Marta, et al.
Publicado: (2013)

Colonic inflammation induces changes in glucose levels through modulation of incretin system
por: Zatorski, Hubert, et al.
Publicado: (2021)

Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases
por: Sutera, Philip, et al.
Publicado: (2018)

Characteristics of colorectal carcinoma patients with PMS2 defects detected by immunohistochemistry
por: Zeng, Zhijun, et al.
Publicado: (2020)

Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma
por: Qiu, Miao‐Zhen, et al.
Publicado: (2021)

Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review
por: Juat, Damie J, et al.
Publicado: (2022)

Second Primary Malignancies in Patients with Colorectal Cancer: A Population‐Based Analysis
por: Jia, Huixun, et al.
Publicado: (2020)

Impact of Sociodemographic Disparities and Insurance Status on Survival of Patients with Early‐Onset Colorectal Cancer
por: Salem, Mohamed E., et al.
Publicado: (2021)

Real‐World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib
por: Patel, Anuj K., et al.
Publicado: (2019)

Age–period–cohort effects in utilization of diagnostic procedures leading to incidental colorectal cancer detection
por: Salvatori, Andrea, et al.
Publicado: (2021)

The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis
por: Sonbol, Mohamad Bassam, et al.
Publicado: (2022)

The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer
por: Fernández Montes, Ana, et al.
Publicado: (2023)

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status
por: André, Thierry, et al.
Publicado: (2013)

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
por: Wang, Chongkai, et al.
Publicado: (2020)

Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02)
por: García‐Albéniz, Xabier, et al.
Publicado: (2019)

Safety and Feasibility of Additional Tumor Debulking to First‐Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer
por: Gootjes, Elske C., et al.
Publicado: (2020)

Bevacizumab in Combination with TAS‐102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study
por: Fujii, Hironori, et al.
Publicado: (2019)

Cetuximab and Irinotecan With or Without Bevacizumab in Refractory Metastatic Colorectal Cancer: BOND-3, an ACCRU Network Randomized Clinical Trial
por: Lipsyc-Sharf, Marla, et al.
Publicado: (2022)

Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss
por: Best, Till Dominik, et al.
Publicado: (2021)

BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer
por: Tan, Elaine, et al.
Publicado: (2022)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Interpretation der Photoplethysmographie: Schritt für Schritt
por: Betz, Konstanze, et al.
Publicado: (2021)

How to: Basics der Schrittmacherprogrammierung
por: Johnson, V., et al.
Publicado: (2022)

Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study
por: Fucà, Giovanni, et al.
Publicado: (2022)

Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis
por: Parikh, Aparna R, et al.
Publicado: (2022)

Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer
por: Wang, Chongkai, et al.
Publicado: (2022)

Extended RAS Analysis of the Phase III EPIC Trial: Irinotecan + Cetuximab Versus Irinotecan as Second‐Line Treatment for Patients with Metastatic Colorectal Cancer
por: Sobrero, Alberto, et al.
Publicado: (2020)

Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical Outcomes
por: Bekaii-Saab, Tanios S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sbg2beg1rgq7iv6j32cumu2uh9